Instead, the association of high ZRANB3 expression with worse prognosis in lung adenocarcinoma (LUAD) may reflect the deleterious effects of certain functional mutations as a strategy used by the tumour to sustain abnormal proliferation (Figure 2C, Supplementary Figure S2 and Table S2). This evidence concerns the gene ZRANB3 and neoplasm.